肺炎球菌血清型的分发和覆盖现有的和管道中的肺炎球菌疫苗
Laura M King1, Kristin L Andrejko2, Miwako Kobayashi2
1School of Public Health, University of California, Berkeley, Berkeley, California, United States.
medRxiv : the preprint server for health sciences
|December 23, 2024
概括
在美国,新的肺炎球菌合疫苗 (PCV) 每年在预防数百万例急性呼吸道感染和数千例侵袭性肺炎球菌病例方面表现有前途,更高的血清型覆盖率,就像PCV31一样,表明疾病预防的潜力更大.
科学领域:
- 传染性疾病 传染性疾病
- 疫苗学 疫苗学 疫苗学
- 公共卫生 公共卫生
背景情况:
- 肺炎链球菌 (pneumococcus) 是侵入性肺炎球菌疾病 (IPD) 和急性呼吸道感染 (ARI) 的主要原因.
- 目前美国的疫苗接种策略包括三种肺炎球菌合疫苗 (PCV),新配方正在开发中.
- 估计现有和新兴PCV对疾病负担的影响对于公共卫生政策至关重要.
研究的目的:
- 确定由当前和管道PCV所覆盖的血清型引起的肺炎球菌ARIs和IPD的比例.
- 估计美国每年的肺炎球菌疾病负担,可以通过PCVs来预防.
主要方法:
- 利用马尔科夫链蒙特卡洛方法分析ARI和IPD中的血清型分布.
- 结合了血清型分布研究和活性细菌核监测 (ABC) 的数据.
- 通过将发病率乘以PCV向比例和疫苗有效性来计算可预防的疾病负担.
主要成果:
- PCV血清型覆盖率有显著的变化,PCV31针对多达68%的儿科AOM和87%的成人肺炎.
- 针对PCV的血清型占儿科病例的42-85%和成人IPD病例的42-94%.
- 估计PCV可预防的负担包括每年27万330万的ARI,200017000的肺炎住院病例和300014000的IPD病例.
结论:
- PCV15显示覆盖率最低,而PCV31显示预防肺炎球菌疾病负担的潜力最高.
- 此外,PCV21还针对相当一部分成人肺炎球菌病.
- 了解不同肺炎球菌疾病中的血清型分布对于优化未来的疫苗开发和公共卫生战略至关重要.
相关概念视频
01:30Pneumonia V: Nursing management and Prevention
1.9K
Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
1.9K
01:51Vaccinations
44.1K
Overview
44.1K
01:30Pneumonia I: Introduction
208
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
208
01:30Pneumonia III: Complications and Assessment
156
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
156
01:28Pneumonia IV: Management
298
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
298
01:29Pneumonia II: Pathophysiology
214
The pathophysiology of pneumonia involves the following steps:
214